Se Young Jang

1.3k total citations
58 papers, 908 citations indexed

About

Se Young Jang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Se Young Jang has authored 58 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 23 papers in Hepatology and 15 papers in Molecular Biology. Recurrent topics in Se Young Jang's work include Liver Disease Diagnosis and Treatment (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Circular RNAs in diseases (8 papers). Se Young Jang is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Circular RNAs in diseases (8 papers). Se Young Jang collaborates with scholars based in South Korea, United States and Sudan. Se Young Jang's co-authors include Soo Young Park, Young Oh Kweon, Won Young Tak, Keun Hur, Yu Rim Lee, Jung Gil Park, Hye Won Lee, Gyeonghwa Kim, Young Seok Han and Jae Min Chun and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Se Young Jang

53 papers receiving 899 citations

Peers

Se Young Jang
Pan Zhao China
Tomoko Tadokoro Japan
Goki Suda Japan
Danting Shen China
Kyoko Oura Japan
Xiaojia Song China
Takenari Yamanaka Japan
Melisa Dirchwolf Argentina
Xiaogang Xiang China
Pan Zhao China
Se Young Jang
Citations per year, relative to Se Young Jang Se Young Jang (= 1×) peers Pan Zhao

Countries citing papers authored by Se Young Jang

Since Specialization
Citations

This map shows the geographic impact of Se Young Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Se Young Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Se Young Jang more than expected).

Fields of papers citing papers by Se Young Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Se Young Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Se Young Jang. The network helps show where Se Young Jang may publish in the future.

Co-authorship network of co-authors of Se Young Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Se Young Jang. A scholar is included among the top collaborators of Se Young Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Se Young Jang. Se Young Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kang, Min Kyu, Jeong Eun Song, Se Young Jang, et al.. (2024). The Clinical Significance of Myosteatosis in Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers. 16(2). 454–454. 5 indexed citations
3.
Kang, Min Kyu, Gyeonghwa Kim, Jung Gil Park, et al.. (2023). Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma. Genes. 14(10). 1963–1963. 8 indexed citations
4.
Baek, Yang Hyun, et al.. (2023). Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. Gut and Liver. 18(2). 283–293. 5 indexed citations
5.
Jang, Se Young, Hwa Jung Kim, & Jun Young Chang. (2023). Association of changes in body mass index and waist circumference with cardiovascular risk in non-alcoholic fatty liver disease: A nationwide study. Digestive and Liver Disease. 55(11). 1509–1514. 1 indexed citations
6.
Kang, Min Kyu, Young Oh Kweon, Won Young Tak, et al.. (2021). Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver. Diagnostics. 11(6). 1061–1061. 12 indexed citations
7.
Hwang, Jae Seok, Woo Jin Chung, Heon Ju Lee, et al.. (2021). Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites. PLoS ONE. 16(6). e0253886–e0253886.
8.
Kim, Gyeonghwa, Soo Young Park, Won Young Tak, et al.. (2021). Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma. Scientific Reports. 11(1). 14930–14930. 7 indexed citations
9.
Park, Jung Gil, Gyeonghwa Kim, Se Young Jang, et al.. (2020). Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis. Life. 10(10). 230–230. 15 indexed citations
10.
Han, Man‐Hoon, Jee Hyun Lee, Gyeonghwa Kim, et al.. (2020). Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Genes. 11(5). 545–545. 35 indexed citations
11.
Jang, Se Young, Won Young Tak, Soo Young Park, et al.. (2020). Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. Annals of Laboratory Medicine. 41(3). 302–309. 20 indexed citations
12.
Lee, Yu Rim, Min Kyu Kang, Jeong Eun Song, et al.. (2020). Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. Clinical and Molecular Hepatology. 26(4). 562–576. 24 indexed citations
13.
Oh, Jae Young, Byung Seok Kim, Chang Hyeong Lee, et al.. (2018). Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world. The Korean Journal of Internal Medicine. 34(4). 794–801. 5 indexed citations
14.
Yoon, Jun Sik, Gyeonghwa Kim, Yu Rim Lee, et al.. (2018). Clinical Significance of Microrna-21 Expression in Disease Progression of Patients With Hepatocellular Carcinoma. Biomarkers in Medicine. 12(10). 1105–1114. 31 indexed citations
15.
Lee, Yu Rim, Gyeonghwa Kim, Won Young Tak, et al.. (2018). Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. International Journal of Cancer. 144(6). 1444–1452. 215 indexed citations
16.
Kim, Mi Jin, Yeon‐Kyung Choi, Soo Young Park, et al.. (2017). PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC. Molecular Cancer Research. 15(9). 1230–1242. 63 indexed citations
17.
18.
Park, Jung Gil, Won Young Tak, Soo Young Park, et al.. (2017). Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report. Oncology Letters. 14(4). 4853–4856. 3 indexed citations
19.
Park, Jung Gil, Yu Rim Lee, Soo Young Park, et al.. (2017). Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B. Digestive and Liver Disease. 50(2). 163–167. 5 indexed citations
20.
Jeon, Young Keul, et al.. (2011). Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1814(10). 1340–1348. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pan Zhao Breakdown of academic impact, for papers by Tomoko Tadokoro Breakdown of academic impact, for papers by Goki Suda Breakdown of academic impact, for papers by Danting Shen Breakdown of academic impact, for papers by Kyoko Oura Breakdown of academic impact, for papers by Xiaojia Song Breakdown of academic impact, for papers by Takenari Yamanaka Breakdown of academic impact, for papers by Melisa Dirchwolf Breakdown of academic impact, for papers by Xiaogang Xiang
Rankless by CCL
2026